Bausch + Lomb, the eye health business of Bausch Health, has partnered with Lochan to develop the new generation of its eyeTELLIGENCE clinical decision support software.

The company initially launched the eyeTELLIGENCE cloud-based digital platform in 2018 to enable surgeons to work smarter and find new ways to use data.

Built on the eyeTELLIGENCE’s existing cloud-based infrastructure, the new-generation analytical software will be designed to help surgeons easily integrate all aspects of the cataract, retinal and refractive surgery processes.

Under the partnership, the companies are planning to launch the initial phase of the eyeTELLIGENCE clinical decision support software by next year.

Bausch + Lomb US president Joseph Gordon said: “Similar to what is being seen across the entire health care spectrum, ophthalmologists are under tremendous pressure to find ways to increase their efficiency and optimise workflow while continuing to deliver the highest level of patient care.

“The need for solutions that help them pursue this goal is massive. In 2018, we started our journey to deliver on this need when we became the first company to connect the operating room to the cloud using our eyeTELLIGENCE technology.

“The agreement with Lochan propels us into the next phase of this journey to further enhance surgeon’s ability to improve practice efficiency.”

Ophthalmic surgical procedures involve a complex, multi-step process that includes patient diagnostics, clinical treatment planning, surgery planning, post-op analysis and more.

Between each step of the procedure, manual transfer of data can be time-consuming and lead to unintended human error.

Bausch + Lomb said that the next-generation eyeTELLIGENCE software platform will be designed to simplify the complex process.

Also, the software would facilitate a more simplified connection from pre-surgery assessment to treatment planning and execution to post-surgery evaluation.

Lochan is a software development firm focused on leveraging advanced analytics and artificial intelligence (AI) to bring novel solutions to complex ophthalmic calculations.

Lochan founder Mark Lobanoff said: “As a practising surgeon, I have experienced first-hand the disconnect that exists between the different phases of the surgical planning process and the lack of interconnectivity between technologies that we use.

“Just as Bausch + Lomb introduced eyeTELLIGENCE to help address these challenges, I founded Lochan because I understood the benefits that digital integration could bring.

“That’s why I believe that together, we will be able to bring the capabilities of eyeTELLIGENCE to the next level — helping surgeons use data to make more informed and faster procedural and treatment decisions.”